Moreover, the available data are derived from observational/cross-sectional studies, and, thus, the ability to establish causal relationships between circulating ANGPTL8 and the development/etiology or progression of NAFLD/MAFLD is intrinsically limited. Here, ANGPTL8 is linked to metabolic dysfunction-associated steatotic liver disease.